These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis. Mykén PS J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulation is necessary in patients with atrial fibrillation after mitral valve replacement with bioprostheses. Rothlin ME Z Kardiol; 1986; 75 Suppl 2():317-20. PubMed ID: 3727710 [No Abstract] [Full Text] [Related]
16. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation. Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711 [No Abstract] [Full Text] [Related]
17. What is the current status of prosthetic cardiac valve replacement? Matloff JM; Chaux A Cardiovasc Clin; 1977; 8(1):241-68. PubMed ID: 849594 [No Abstract] [Full Text] [Related]
18. Short- and long-term results of triple valve surgery in the modern era. Alsoufi B; Rao V; Borger MA; Maganti M; Armstrong S; Feindel CM; Scully HE; David TE Ann Thorac Surg; 2006 Jun; 81(6):2172-7; discussion 2177-8. PubMed ID: 16731149 [TBL] [Abstract][Full Text] [Related]